@article{cbda5afade03439d8270218863db7669,
title = "ACR Stakeholder Prostate Summit",
author = "Jeffrey Weinreb and Peter Choyke and Andrei Iagaru and Joseph Ippolito and Mark Lockhart and Gregory Merrick and Sean Sachdev and Ezequiel Silva and Taneja, {Samir S.} and Clare Tempany and Richard Wahl and Andrew Rosenkrantz",
note = "Funding Information: Peter Choyke, MD has a patent for MRI US fusion biopsy method with royalties paid to In Vivo, and a patent computer aided design (CAD) for artificial intelligence system to diagnose prostate cancer on MRI with royalties paid to In Vivo Scan Med. He has a clinical trials agreement (nonfinancial) with Progenics (producer of F18 DCFPyl, a prostate-specific membrane antigen imaging agent). Andrei Iagaru, MD, has received grants from GE Healthcare , Advanced Accelerator Applications, and Progenics Pharmaceuticals. Samir S. Taneja, MD, reports personal fees from Trod Medical, personal fees and other from Sophiris, personal fees from Insightec, personal fees from Francis Medical, outside the submitted work. Clare Tempany, MD has grants from National Institutes of Health /National Institute of Biomedical Imaging and Bioengineering ( NIBIB) EB 015898 and has received personal fees from Profound Medical. Richard Wahl, MD, is a shareholder in Progenics. Andrew Rosenkrantz, MD has received personal fees from Thieme Medical Publishers. The other authors state that they have no conflict of interest related to the material discussed in this article. ",
year = "2020",
month = aug,
doi = "10.1016/j.jacr.2020.03.031",
language = "English (US)",
volume = "17",
pages = "1068--1070",
journal = "Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "8",
}